Haima Therapeutics has executed an exclusive license agreement with Case Western Reserve University to research, develop and market artificial platelet technologies to treat patients with various ...

Opportunities also lie in synthetic bioactive hemostats and digital health integration for improved outcomesDublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Hemostasis Market - A Global and Regional ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S.

Non-compressible hemorrhage control is a challenging topic both on the battlefields and in civilian life. Blooming in the non-compressible hemostatic materials development emerged in recent years and ...

Although there is no clinical evidence of a role for the hemostatic system in the progression of atherosclerosis, ample experimental data indicate that platelets and the coagulation system are ...

A hemostatic powder, TC-325 (Hemospray), worked as well as standard treatment for endoscopic control of acute bleeds from nonvariceal upper gastrointestinal lesions, a randomized trial found. In the ...

Uncontrolled bleeding is still the number one preventable cause of death in combat. That hasn’t changed. Tourniquets changed the game. Hemostatic gauze like QuikClot Combat Gauze changed it again. Now ...

Effect of DeltaRex-G ± DeltaRex-G Plus (an FDA-approved drug) on advanced chemoresistant pancreatic cancer, sarcoma, and breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...

The global hemostatic gels market, valued at USD 1.0 billion in 2022, is set to experience significant growth, projected to reach USD 1.9 billion by 2032, expanding at a compound annual growth rate ...

Finding real-life instances of innovations that seem too good to be true is always a rewarding experience. And search no further, friends, as we now have a real proof of concept for a truly ...